跳至主要内容
临床试验/NCT02231697
NCT02231697已完成不适用

The RECENSUS Study: A Medical Chart Review of Patients With X-Linked Myotubular Myopathy (XLMTM)

Astellas Gene Therapies8 个研究点 分布在 2 个国家目标入组 161 人开始时间: 2014年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
161
试验地点
8
主要终点
Survival

研究概览

简要总结

This retrospective medical chart review (RECENSUS) of approximately 100 XLMTM patients (with a goal to obtain 50 deceased and 20 living records) will provide further knowledge about the clinical manifestations and recorded medical management of XLMTM and potentially inform the design of future therapeutic intervention studies.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

性别
Male
接受健康志愿者

入选标准

  • Patient diagnosed with XLMTM resulting from a confirmed mutation in the MTM1 gene, or a combination of XLMTM genetically confirmed family history and muscle biopsy
  • Patient is male
  • Access to available medical records for each patient
  • Signed informed consent by the parent(s) or legal guardians and/or assent by the patient (when applicable), unless the associated IRB provides an appropriate consent waiver

排除标准

  • Patient data after participation in an interventional study designed to treat XLMTM (patient data prior to participation in an interventional study may be included)

结局指标

主要结局

Survival

时间窗: Lifetime, up to 50 years

Descriptive statistics: mean, median, range for age at death for deceased patients, mean, median, range for current age for living patients

次要结局

  • Age at diagnosis(Lifetime, up to 50 years)
  • Age at tracheostomy (if applicable)(Lifetime, up to 50 years)
  • Age at need for/type of ventilation (if applicable)(Lifetime, up to 50 years)

研究者

发起方
Astellas Gene Therapies
申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验